Becoming a Critical Actor—Learning about Improving Equity and Inclusion in the Workplace
The recent Women in Thoracic Oncology Networking Event provided its audience with the rare opportunity to speak openly and honestly about challenges in the workforce, from microaggressions to wage gaps […] Read more
LGBT Cancer Survivors and Disparities-Related Barriers That May Affect Survival
Beth Fand IncollingoCancer survivors who are lesbian, gay, bisexual, or transgender (LGBT) face potentially survival-limiting health disparities, and this should be addressed by the healthcare system. Those were the findings of a […] Read more
Distressed Due to Pandemic, Patients with Lung Cancer Seek Educational Resources
Beth Fand IncollingoA Canadian survey conducted repeatedly throughout the COVID-19 pandemic reflects a rise in feelings of isolation and vulnerability among patients with lung cancer. Survey results indicate that patients want educational […] Read more
Practice-Changing Initiatives Benefit the Medical Team, Patients
The social and emotional needs of patients are increasingly being recognized as equally important to their physical needs, and use of multidisciplinary teams is helping to bridge the gaps between […] Read more
Addressing Lung Cancer Screening Disparities in the LGBT Community
Lauren Evoy DavisHistorically, sexual minorities have been underserved in the healthcare setting. Members of this patient population may be less likely to receive optimal care, especially when it comes to preventive care […] Read more
Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors
Although the initial research into adoptive T-cell therapy for solid tumors was related to tumor-infiltrating lymphocytes, there is a growing interest in the use of adoptive T-cell therapy for the […] Read more
Mobocertinib May Offer Effective, Safe Treatment in NSCLC with EGFR Exon 20 Insertion Mutation
Beth Fand IncollingoWith no approved treatments for advanced NSCLC with EGFR exon 20 insertion mutations, treatment is mainly limited to chemotherapy, as these cancers don’t respond to traditional tyrosine kinase inhibitors (TKIs). […] Read more
More Data Needed on Benefit of Adaptive Radiation Approaches in Locally-Advanced NSCLC
The results of one phase II study looking at PET/CT-guided adaptive radiation therapy and one PET boost trial in locally advanced NSCLC were presented in an Oral Abstract Session (OA2). […] Read more
Study Identifies Lung Cancer Areas of Improvement Across Asia-Pacific Region
Lung cancer prevention and treatment remains a challenge across the Asia-Pacific region, and each country has areas where they could improve, according to a study presented during the Day 2 […] Read more
Several Studies Assess the Fallout From the COVID-19 Pandemic in Patients With Lung Cancer
Kara Nyberg, PhDThe COVID-19 pandemic has undoubtedly altered patient care as countries have locked down to prevent spread of the virus and shifted resources to accommodate surging caseloads. It has also taken […] Read more